Evidence map›Paper›PMID 27171266›Full record

ArticleCell death & disease2016

Chitohexaose protects against acetaminophen-induced hepatotoxicity in mice.

P K Barman, R Mukherjee, B K Prusty, S Suklabaidya, S Senapati, B Ravindran

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
6.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Preliminary studies on therapeutic effect of ethanolic extract ofJournal of traditional and complementary medicine · 2019
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

P K BarmanInfectious Disease Biology Group, Institute of Life Sciences, Bhubaneswar, India.
R MukherjeeInfectious Disease Biology Group, Institute of Life Sciences, Bhubaneswar, India.
B K PrustyInfectious Disease Biology Group, Institute of Life Sciences, Bhubaneswar, India.
S SuklabaidyaTranslational Research Group, Institute of Life Sciences, Bhubaneswar, India.
S SenapatiTranslational Research Group, Institute of Life Sciences, Bhubaneswar, India.
B RavindranInfectious Disease Biology Group, Institute of Life Sciences, Bhubaneswar, India.
Institute of Life Sciences · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acetaminophen (N-acetyl-para-aminophenol (APAP)) toxicity causes acute liver failure by inducing centrilobular hepatic damage as a consequence of mitochondrial oxidative stress. Sterile inflammation, triggered by hepatic damage, facilitates gut bacterial translocation leading to systemic inflammation; TLR4-mediated activation by LPS has been shown to have a critical role in APAP-mediated hepatotoxicity. In this study, we demonstrate significant protection mediated by chitohexaose (Chtx) in mice challenged with a lethal dose of APAP (400 mg/kg b.w.). Decreased mortality by Chtx was associated with reduced hepatic damage, increased peritoneal migration of neutrophils, decreased mRNA expression of IL-1β as well as inhibition of inflammasome activation in liver. Further, an alternate mouse model of co-administration of a sublethal doses of APAP (200 mg/kg b.w.) and LPS (5 mg/kg b.w.) operating synergistically and mediating complete mortality was developed. Overwhelming inflammation, characterized by increased inflammatory cytokines (TNF-α, IL-1β and so on) in liver as well as in circulation and mortality was demonstrable in this model. Also, Chtx administration mediated significant reversal of mortality in APAP+LPS co-administered mice, which was associated with reduced IL-1β in liver and plasma cytokines in this model. In conclusion, Chtx being a small molecular weight linear carbohydrate offers promise for clinical management of liver failure associated with APAP overdose.

Indexed as

AcetaminophenAnimalsAnti-Inflammatory Agents, Non-SteroidalChemical and Drug Induced Liver InjuryDisease Models, AnimalDrug Administration ScheduleGene Expression RegulationHepatitis, AnimalInjections, IntraperitonealInterleukin-1betaLipopolysaccharidesLiverMaleMiceMice, Inbred C57BLNeutrophil InfiltrationAcetaminophenAnti-Inflammatory Agents, Non-SteroidalchitohexaoseIL1B protein, mouseInterleukin-1betaLipopolysaccharidesOligosaccharidesTumor Necrosis Factor-alpha

Identifiers

PMID27171266
PMCPMC4917664
OpenAlexW2388416488

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.